Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Proliferative Retinopathy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01102946
What this trial is testing

Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic Retinopathy

Who this might be right for
Diabetic RetinopathyRetinal Neovascularization
University of Sao Paulo 40
Not applicableStudy completedNCT06653361
What this trial is testing

Ultra-Widefield Fluorescein Angiography-Based Targeted Retinal Photocoagulation Versus Conventional Panretinal Photocoagulation in the Preservation of Visual Function and Regression of Proliferative Diabetic Retinopathy

Who this might be right for
Proliferative Diabetic Retinopathy - High Risk
Hayatabad Medical Complex 120
Not applicableUnknownNCT04682054
What this trial is testing

Molecular Taxonomy of Surgically-harvested Ocular Tissues Defined by Single-cell Transcriptomics

Who this might be right for
Diabetic RetinopathyProliferative VitreoretinopathyPterygium+1 more
The First Affiliated Hospital with Nanjing Medical University 80
Not applicableUnknownNCT05631054
What this trial is testing

Establishment and Validation of a Risk Prediction Model for Long-term Low Vision After Vitrectomy in PDR Patients

Who this might be right for
Proliferative Diabetic RetinopathyPars Plana VitrectomyRisk Prediction Model
Tianjin Medical University Eye Hospital 250
Not applicableLooking for participantsNCT06899529
What this trial is testing

Immediate Postoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy

Who this might be right for
Proliferative Diabetic Retinopathy - High Risk
Christian Ophthalmic Surgery Expedition Network 150
Large-scale testing (Phase 3)Looking for participantsNCT06817265
What this trial is testing

Clinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic Retinopathy

Who this might be right for
Non-Proliferative Diabetic Retinopathy
Beletalent (Zhuhai) Pharmaceutical Co., Ltd 360
Testing effectiveness (Phase 2)Active Not RecruitingNCT06321302
What this trial is testing

Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Boehringer Ingelheim 190
Post-approval studies (Phase 4)Enrolling By InvitationNCT06191094
What this trial is testing

Pre-operative Vabysmo in Patients With Non-clearing Vitreous Hemorrhage Secondary to Proliferative Diabetic Retinopathy

Who this might be right for
Diabetic RetinopathyVitreous Hemorrhage Due to Diabetes Mellitus
University of Colorado, Denver 100
Not applicableStudy completedNCT07058337
What this trial is testing

Methotrexate in Retinal Detachment With Proliferative Vitreoretinopathy

Who this might be right for
Retinal Detachment
Benha University 20
Not applicableEnded earlyNCT01737957
What this trial is testing

Safety and Efficacy of Low-Fluence PRP for PDR

Who this might be right for
Proliferative Diabetic Retinopathy
Asociación para Evitar la Ceguera en México 60
Testing effectiveness (Phase 2)WithdrawnNCT00727038
What this trial is testing

Lucentis for New Onset Neovascular Glaucoma

Who this might be right for
GlaucomaNew Onset GlaucomaNeovascular Glaucoma+1 more
University of Illinois at Chicago
Large-scale testing (Phase 3)UnknownNCT00908778
What this trial is testing

A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects

Who this might be right for
Diabetic Retinopathy
Vitreoretinal Technologies, Inc. 160
Not applicableStudy completedNCT04285151
What this trial is testing

Nd:YAG Laser Hyaloidotomy for Premacular Hemorrhage in Diabetic Eyes

Who this might be right for
Proliferative Diabetic Retinopathy
Tanta University 25
Testing effectiveness (Phase 2)Study completedNCT02435862
What this trial is testing

A Clinical Trial Designed to Evaluate the Safety and Efficacy Study of Luminate® in Inducing PVD (Posterior Vitreous Detachment) in Non-Proliferative Diabetic Retinopathy

Who this might be right for
Non-Proliferative Diabetic Retinopathy
Allegro Ophthalmics, LLC 105
Large-scale testing (Phase 3)Study completedNCT04278417
What this trial is testing

Study of Efficacy and Safety of Brolucizumab Versus Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy

Who this might be right for
Proliferative Diabetic Retinopathy
Novartis Pharmaceuticals 689
Not applicableLooking for participantsNCT06549023
What this trial is testing

Single Session vs Multiple-Session Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy

Who this might be right for
Proliferative Diabetic RetinopathyDiabetic RetinopathyDiabetic Retinopathy Visually Threatening+3 more
Vastra Gotaland Region 40
Post-approval studies (Phase 4)Active Not RecruitingNCT07118670
What this trial is testing

High Dose Eylea for Proliferative Diabetic Retinopathy Outcomes

Who this might be right for
Proliferative Diabetic Retinopathy (PDR)
Edward Wood, MD 40
Testing effectiveness (Phase 2)Study completedNCT05681884
What this trial is testing

Safety and Efficacy of Faricimab in Patients With NPDR

Who this might be right for
Non-Proliferative Diabetic Retinopathy
Greater Houston Retina Research 179
Early research (Phase 1)WithdrawnNCT04830878
What this trial is testing

Methotrexate For The Prevention and Treatment of Proliferative Vitreoretinopathy in Pediatric Patients

Who this might be right for
Proliferative Vitreoretinopathy
Stanford University
Post-approval studies (Phase 4)Study completedNCT07230184
What this trial is testing

To Evaluate the Efficacy and Safety of Combination Therapy With B55R1 and B55R2 Compared to B55R1 Monotherapy in Patients With NPDR

Who this might be right for
Non-Proliferative Diabetic Retinopathy
AJU Pharm Co., Ltd. 53
Next Page